MARKET

KPRX

KPRX

KIORA PHARMACEUTICALS INC
NASDAQ
3.540
-0.020
-0.56%
After Hours: 3.610 +0.07 +1.98% 19:38 02/03 EST
OPEN
3.430
PREV CLOSE
3.560
HIGH
3.610
LOW
3.430
VOLUME
41.26K
TURNOVER
0
52 WEEK HIGH
39.18
52 WEEK LOW
2.320
MARKET CAP
6.36M
P/E (TTM)
-0.0876
1D
5D
1M
3M
1Y
5Y
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 01/11 13:05
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga · 01/06 18:16
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 01/06 17:30
Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga · 01/05 18:01
KALA, KC and CTMX are among pre market gainers
Seeking Alpha · 01/05 13:28
Why Geron Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
Benzinga · 01/05 13:01
H.C. Wainwright Sticks to Its Buy Rating for Kiora Pharmaceuticals (KPRX)
TipRanks · 01/04 11:15
Kiora Pharmaceuticals Completes Enrollment in Eye Therapy KIO-201 Study
Kiora Pharmaceuticals Completes Enrollment in Eye Therapy KIO-201 Study
MT Newswires · 01/03 15:07
More
About KPRX
Kiora Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on developing and commercializing therapies for the treatment of ophthalmic diseases. Its pipeline consists of three product candidates, including KIO-101, KIO-301, and KIO-201. Its lead product, KIO-301, is a potential vision-restoring small molecule that is designed to restore vision in patients with inherited and age-related degenerative retinal diseases. KIO-101 is a non-steroidal, immuno-modulatory, small-molecule inhibitor of Dihydroorotate Dehydrogenase (DHODH) that focuses on patients with Ocular Presentation of Rheumatoid Arthritis (OPRA). Its KIO-201 is a synthetic modified hyaluronic acid (HA) capable of coating the ocular surface and designed to resist degradation under conditions present in the eye. Its wholly owned subsidiaries include Jade Therapeutics, Inc., Kiora Pharmaceuticals, GmbH, Bayon Therapeutics, Inc. and Kiora Pharmaceuticals Pty Ltd.

Webull offers kinds of Kiora Pharmaceuticals Inc stock information, including NASDAQ:KPRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KPRX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading KPRX stock methods without spending real money on the virtual paper trading platform.